return to news
  1. Who Else Benefits From A Large Defence Shipbuilding Project

Market News

Who Else Benefits From A Large Defence Shipbuilding Project

Upstox

13m 20s | Updated on November 02, 2026, 08:15 IST

SUMMARY

In this episode of Markets Today, we decode 3 big stories — India’s ₹40,000 crore corvette project, the Ather vs Ola range debate, and rising institutional holdings in four pharma stocks. GRSE and Goa Shipyard will build eight next generation corvettes, while Ather and Ola take different approaches to range. Gujarat Themis Biosyn, Torrent Pharma, Cipla and Rubicon Research also saw higher institutional holdings.

In this episode of Markets Today, we decode 3 big stories — India’s ₹40,000 crore corvette project, the Ather vs Ola range debate, and four pharma stocks where institutional holdings rose.

₹40,000 Crore For Eight Corvettes The Cabinet Committee on Security cleared eight Next-Generation Corvettes with a Navy-designed stealth hull. GRSE and Goa Shipyard will build them, with the first delivery targeted by 2030.

Ather vs Ola: How Much Range Is Enough? Ather says its average customer rides 27-28 km a day and is preparing an 80-90 km Konarc variant, while Ola is pushing a ~300 km scooter. Range anxiety is still a real concern for some buyers.

Four Pharma Stocks With Rising Institutional Holdings DII holdings rose in Gujarat Themis Biosyn (1.17% to 12.65%), Torrent Pharma, Cipla and Rubicon Research. Holdings show interest, not a reason to buy, and Cipla faces USFDA inspection actions.

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Next Story

End of additional stories